Tapinarof, however, offers a potential solution by improving the skin barrier, reducing inflammation and relieving itch ...

FDA 2025 pulmonology drug alerts, including drug approvals/warnings, vaccine approvals, and medical device recalls/updates.

Atopic dermatitis is a chronic inflammatory skin disease affecting a growing number of people worldwide. Marked by persistent ...

Ruxolitinib cream 1.5% was safe and effective for the treatment of children and adolescents with a 35% or greater body surface areas affected by atopic dermatitis, according to a study.Ruxolitinib ...

Patients with atopic dermatitis aged 2 years and older who used tapinarof cream 1% had significant improvements in various patient-reported outcomes.

AD, The most common inflammatory skin disorder worldwide, is a highly heterogeneous condition with current treatments that do ...

Arcutis Biotherapeutics is going long with the latest push for its seborrheic dermatitis treatment Zoryve. | Arcutis ...

The celebrity dermatologist talks about finding her moment of clarity in finding relief for her eczema symptoms and how she ...

As temperatures drop, many people experience dry, red, and itchy skin, a condition that often worsens in winter.

Atopic dermatitis, or eczema ... such as antihistamines topical creams with a steroid to relieve itchiness and inflammation anti-inflammatory medications Doctors will typically recommend ...

Financial writer analysis of Arcutis Biotherapeutics, Inc. stock surge and potential growth, FDA approvals, and partnerships ...

• Topical treatments: Over-the-counter 1% hydrocortisone cream can help with mild flare-ups. For more severe cases, pediatricians may prescribe stronger topical steroids or calcineurin inhibitors.